Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, 44106-1702, United States
NCT Number: NCT04599036
Stroke is a medically relevant problem for the aging population. Individuals with stroke experience a high amount of arm functional deficits despite receiving rehabilitation. Functional deficits can be improved by combining rehabilitation with innovative rehabilitative tools that target the brain mechanisms that guide the recovery early after stroke. This study aims to explore the feasibility of implementing an EMG controlled device in the acute rehabilitation for stroke survivors with severe arm deficit. This study will determine if adding such a technology improve the clinical outcomes for subjects with severe arm impairments beyond the levels achieved by standard care in attempt to increase their chances to independently perform activities of daily living.
This study is active but is not currently recruiting participants.
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Cleveland, Ohio, 44106-1702, United States
During the first weeks after the onset of stroke, the injured brain undergoes several neural mechanisms, a process known as neuroplasticity, that intend to reorganize the neural connectivity and repair the damaged tissue around the injury region. Several studies revealed that rehabilitation during this acute period of injury would enhance the functional outcome of the paretic arm presumably by modulating the heightened neuroplastic mechanism. Specifically, it has been suggested that novel interventions that interact with the neuroplastic mechanisms of recovery are particularly needed for stroke survivors whom initial arm impairments are severe.
The rationale of this study is to explore if an EMG controlled device can be added to the acute rehabilitation for stroke subjects with severe arm deficit. The study will also investigate if the application of such a device would lead to an even better enhancement of clinical outcomes compared to standard care. Because of such neurophysiological changes during the acute phase, the study aims to correlate the neurophysiological changes with the enhancement gained as a result of practicing with an EMG controlled device in this population. Thus, test the premise that adding practice with an EMG controlled device to the acute rehabilitation of subjects with severe arm impairments acts as novel rehabilitative tool that interact with the neuroplastic mechanisms of recovery to enhance clinical outcomes for these subjects.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Healthy Controls:
Over 18 years of age No history of neurological or muscular problems that affect arm function
Exclusion criteria
Hemorrhagic stroke
EMG controlled arm orthosis
Time frame: Change from Baseline arm impairment after 6 weeks
Measure of arm impairment. Scores on the FMA may range from 0-66 points, with higher score indicating better performance.
Time frame: Change from Baseline arm function after 6 weeks
Measure of arm function. Scores on the ARAT may range from 0-57 points, with higher score indicating better performance.
VA Office of Research and Development
Fed
Myoelectrolytically Controlled Device in Acute Rehabilitation After Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739134
ALS, Brain Damage, Chronic
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT05047172
Arterial Occlusive Diseases, Arteriosclerosis
Birmingham, Alabama, United States
View Trial DetailsNCT07710937
Brain Diseases, Cardiovascular Diseases
Multan Khurd, Pakistan
View Trial DetailsNCT07666906
Brain Diseases, Cardiovascular Diseases
Faisalābad, Punjab Province, Pakistan
View Trial Details